DAVID V SMITH Insider Trading $ACHV ACHIEVE LIFE SCIENCES, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DAVID V SMITH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DAVID V SMITH. DAVID V SMITH is V.P. & Chief Financial Officer in CHIRON CORP ($CHIR) and V.P.; Chief Financial Officer in CHIRON CORP ($CHIR) and Director in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and Executive Vice President & CFO in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in CODEXIS INC ($CDXS).

DAVID V SMITH in ACHIEVE LIFE SCIENCES, INC.

Trading Symbol: ACHV
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DAVID V SMITH: Director
Holdings: 9,500 shares
Current Value: $5,700
Latest Transaction: May 27 2016
$ACHV Market Capitalization: $18.31M
$ACHV Previous Close: $0.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of DAVID V SMITH in ACHIEVE LIFE SCIENCES, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACHV, CHIR, CDXS, FPRX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 27 2016OGXIONCOGENEX PHARMACE ...Smith David VDirectorOption ExerciseA1.0022,50022,50022,500
May 24 2016OGXIONCOGENEX PHARMACE ...Smith David VDirectorOption ExerciseM0.002,50000
May 24 2016OGXIONCOGENEX PHARMACE ...Smith David VDirectorBuyM0.002,50009,5007 K to 9.5 K (+35.71 %)
May 22 2015OGXIONCOGENEX PHARMACE ...Smith David VDirectorOption ExerciseA0.002,50002,500
May 22 2015OGXIONCOGENEX PHARMACE ...Smith David VDirectorOption ExerciseA1.895,0009,4505,000
May 22 2015OGXIONCOGENEX PHARMACE ...Smith David VDirectorOption ExerciseM0.002,50000
May 22 2015OGXIONCOGENEX PHARMACE ...Smith David VDirectorBuyM0.002,50007,0004.5 K to 7 K (+55.56 %)

Page:   1